Clinical Research Division
Photo by Susan Lemmon/ Fred Hutch
Bone marrow transplantation demonstrated that the human immune system could be harnessed to cure cancer. Now Dr. Stanley Riddell and his Fred Hutch colleagues are developing successful treatments that use the immune system to fight a variety of diseases, much as it eliminates everyday infections like the common cold.
This revolutionary approach, called immunotherapy, yields effective cancer treatments with far fewer side effects than conventional drugs, radiation or surgery.
Our goal is to make immunotherapy as successful for many cancers as bone marrow transplantation has been for leukemia.
Study volunteers will go through a screening process to determine eligibility. Eligible donors are added to our database for study enrollment. The Clinical Research Coordinator will contact donors depending on the specific needs of the laboratory.
Each donor is requested to donate 400 cc of blood. The compensation is $60 for full collection. Blood draw events are held every other month, excluding holidays, on the Fred Hutch campus.
Eligible donors will be invited to attend a blood draw donation event. Appointments are about 15-30 minutes long and are scheduled in the morning.
There is no direct benefit to study participants. Since the process involves a venipuncture, there will be some discomfort and potential bruising at the site of the blood draw. Study participants may withdraw from the study at any time.
If you would like to be added to our database of donors we will need to verify that you are an eligible donor. You may contact us at Immunobd@fredhutch.org for eligibility screening and further details.